Defective DNA repair in hereditary ovarian cancers: Implications for therapy

Overview of attention for article published in American Journal of Health-System Pharmacy, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy: 1 policy source

twitter: 6 X users

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 36,997 followers.

RT @gedefo_sefh: "Defective DNA repair in hereditary ovarian cancers: Implications for therapy [Defective DNA Repair]" https://t.co/NpPiLN…

"Defective DNA repair in hereditary ovarian cancers: Implications for therapy [Defective DNA Repair]" https://t.co/NpPiLNFUwA

Defective DNA repair in hereditary ovarian cancers: Implications for therapy [Defective DNA Repair] https://t.co/fu3G3Ks2Ev https://t.co/Ay9G3uDJlf

PARP inhibitors and immune checkpoint inhibitor exploit defective DNA repair in hereditary ovarian cancers. https://t.co/TFz9ASKyU5

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.